AI assistant
Sending…
Lotus Pharm — Proxy Solicitation & Information Statement 2019
Jul 1, 2019
51923_rns_2019-07-01_0e74a919-537f-4e89-a845-abc13e90d3ee.pdf
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
==> picture [160 x 37] intentionally omitted <==
Meeting Notice
For
2019 First Extraordinary General Meeting
(Summary Translation)
The 2019 First Extraordinary General Meeting (the “Meeting”) of Lotus Pharmaceutical Co., Ltd. (the “Company”) will be convened at 9:00 a.m., Wednesday, February 20[th] , 2019 at No.21, Nangang 3[rd] Rd., Nantou City, Nantou County 540, Taiwan (R.O.C.), and
The Agenda for the Meeting is as follows:
I. Discussion Items:
(1) Proposal for private placement
II. Special Motions
III. Adjournment
Board of Directors
Lotus Pharmaceutical Co., Ltd.
More from Lotus Pharm
Capital/Financing Update
2026
May 21
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12